Sterling Capital Management LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1329883 CHARLOTTE, NC

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$9,579,569

-$4,004,309 QoQ

Shares Held

282,750

-37.3% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#152

of 671 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Sterling Capital Management LLC holds $17,469,343 across 46 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (54.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd This page	282,750	$9,579,569
2	VTRS	Viatris Inc	227,731	$3,616,368
3	HLN	Haleon plc	86,415	$806,251
4	UTHR	UNITED THERAPEUTICS Corp	1,246	$675,120
5	NBIX	Neurocrine Biosciences Inc	3,601	$606,912
6	LNTH	Lantheus Holdings, Inc.	4,527	$502,225
7	ELAN	Elanco Animal Health Inc	14,866	$365,852
8	ZTS	Zoetis Inc.	5,017	$360,521

All Filings in TEVA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,579,569	282,750	-37.3%	Shares	Sole	2026-07-28
2026-03-31	$13,583,878	450,992	-47.5%	Shares	Sole	2026-04-22
2025-12-31	$26,815,257	859,188	-42.8%	Shares	Sole	2026-02-13
2025-09-30	$30,333,552	1,501,661	+0.9%	Shares	Sole	2025-11-12
2025-06-30	$24,938,410	1,487,972	-27.1%	Shares	Sole	2025-08-08
2025-03-31	$31,358,411	2,040,235	-1.5%	Shares	Sole	2025-05-13
2024-12-31	$45,663,640	2,071,853	-10.3%	Shares	Sole	2025-02-13
2024-09-30	$41,608,936	2,309,042	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.